Cargando…
Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645469/ http://dx.doi.org/10.1186/2051-1426-3-S2-P138 |
| _version_ | 1782400819564380160 |
|---|---|
| author | Kwan, Nathan H Ockenfels, Brittany A Patel, Charmi Miletello, Gerald P Brantley, Paula R |
| author_facet | Kwan, Nathan H Ockenfels, Brittany A Patel, Charmi Miletello, Gerald P Brantley, Paula R |
| author_sort | Kwan, Nathan H |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645469 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46454692015-11-20 Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy Kwan, Nathan H Ockenfels, Brittany A Patel, Charmi Miletello, Gerald P Brantley, Paula R J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645469/ http://dx.doi.org/10.1186/2051-1426-3-S2-P138 Text en Copyright © 2015 Kwan et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Kwan, Nathan H Ockenfels, Brittany A Patel, Charmi Miletello, Gerald P Brantley, Paula R Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| title | Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| title_full | Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| title_fullStr | Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| title_full_unstemmed | Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| title_short | Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| title_sort | stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645469/ http://dx.doi.org/10.1186/2051-1426-3-S2-P138 |
| work_keys_str_mv | AT kwannathanh stablediseasediagnosisanddoseareprognosticfactorsforsurvivalafterinterleukin2immunotherapy AT ockenfelsbrittanya stablediseasediagnosisanddoseareprognosticfactorsforsurvivalafterinterleukin2immunotherapy AT patelcharmi stablediseasediagnosisanddoseareprognosticfactorsforsurvivalafterinterleukin2immunotherapy AT miletellogeraldp stablediseasediagnosisanddoseareprognosticfactorsforsurvivalafterinterleukin2immunotherapy AT brantleypaular stablediseasediagnosisanddoseareprognosticfactorsforsurvivalafterinterleukin2immunotherapy |